NEPHSTROM PIs Matthew Griffin of the National University of Ireland, Galway and Norberto Perico of the Istituto di Ricerche Farmacologiche Mario Negri (IRFMN) were involved in presentations at the American Society of Nephrology Kidney Week, San Diego, USA. The meeting which ran from the 23-28 October 2018 is the largest international conference for Nephrology.
Norberto Perico, MD gave an invited talk on “Mesenchymal Stem Cell Therapies in DKD: The NEPHSTROM Experience” on October 27, 2018, as part of a session entitled “Diabetic Kidney Disease: New Tricks for Old Targets”. Prof Matthew Griffin was a moderator of the aforementioned session.
Kidney Week provided participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.
Prof. Griffin noted: “Diabetic kidney disease was a very hot topic at this year’s Kidney Week. It is clear that the Nephrology community is highly motivated to bring novel and personalised therapies into the clinical arena and to better understand their mechanisms of action in human subjects. Dr. Perico’s presentation was part of a well-attended session dedicated to novel therapeutic targets in DKD and stimulated insightful questions and discussion from audience members about the safety, efficacy and immunological effects of systemic mesenchymal stromal cell administration in people with CKD due to diabetes. The ongoing NEPHSTROM clinical trial is specifically designed to address such key questions”.